StreetInsider.com News Articles

Adobe, Salesforce and Intuit fall as Morgan Stanley begins cautious coverage

Tue, 21 Jul 2026 07:28:25 -0400

Investing.com -- Morgan Stanley took a mixed stance on software stocks Tuesday, growing bearish on Adobe and Workday even as it maintained an ’Attractive’ view on the sector overall.

Adobe fell 3.8% in premarket trading Tuesday, while Salesforce and Intuit slid 2.9% and 4.3%, respectively. Workday shares also dipped 4.2%.

Analysts led by Adam Wood started Adobe at Underweight with a $240 price target, citing concerns that the company faces multiple transitions at once. Adobe’s shift toward freemium pricing, along with changes in its CEO and CFO, and a move toward heavier AI reinvestment, "elongate the

Adobe, Salesforce and Intuit fall as Morgan Stanley begins cautious coverage

Tue, 21 Jul 2026 07:28:25 -0400

Investing.com -- Morgan Stanley took a mixed stance on software stocks Tuesday, growing bearish on Adobe and Workday even as it maintained an ’Attractive’ view on the sector overall.

Adobe fell 3.8% in premarket trading Tuesday, while Salesforce and Intuit slid 2.9% and 4.3%, respectively. Workday shares also dipped 4.2%.

Adobe, Salesforce and Intuit fall as Morgan Stanley begins cautious coverage

Tue, 21 Jul 2026 07:28:25 -0400

Investing.com -- Morgan Stanley took a mixed stance on software stocks Tuesday, growing bearish on Adobe and Workday even as it maintained an ’Attractive’ view on the sector overall.

Adobe fell 3.8% in premarket trading Tuesday, while Salesforce and Intuit slid 2.9% and 4.3%, respectively. Workday shares also dipped 4.2%.

Adobe, Salesforce and Intuit fall as Morgan Stanley begins cautious coverage

Tue, 21 Jul 2026 07:28:25 -0400

Investing.com -- Morgan Stanley took a mixed stance on software stocks Tuesday, growing bearish on Adobe and Workday even as it maintained an ’Attractive’ view on the sector overall.

Adobe fell 3.8% in premarket trading Tuesday, while Salesforce and Intuit slid 2.9% and 4.3%, respectively. Workday shares also dipped 4.2%.

Adobe, Salesforce and Intuit fall as Morgan Stanley begins cautious coverage

Tue, 21 Jul 2026 07:28:25 -0400

Investing.com -- Morgan Stanley took a mixed stance on software stocks Tuesday, growing bearish on Adobe and Workday even as it maintained an ’Attractive’ view on the sector overall.

Adobe fell 3.8% in premarket trading Tuesday, while Salesforce and Intuit slid 2.9% and 4.3%, respectively. Workday shares also dipped 4.2%.

Adobe, Salesforce and Intuit fall as Morgan Stanley begins cautious coverage

Tue, 21 Jul 2026 07:28:25 -0400

Investing.com -- Morgan Stanley took a mixed stance on software stocks Tuesday, growing bearish on Adobe and Workday even as it maintained an ’Attractive’ view on the sector overall.

Adobe fell 3.8% in premarket trading Tuesday, while Salesforce and Intuit slid 2.9% and 4.3%, respectively. Workday shares also dipped 4.2%.

Morgan Stanley Downgrades Intuit (INTU) to Equalweight

Tue, 21 Jul 2026 02:35:37 -0400

Morgan Stanley analyst Adam Wood downgraded Intuit (NASDAQ: INTU) from Overweight to Equalweight with a price target of $335.00 (from $580.00).

The analyst comments: “Downgrade to Equal-weight on 3 Key Points:

1. Tax Overhang. With the key investor debate on the stock centering around the viability of the TurboTax business, the AI disruption bear case will likely not be dispelled until F3Q results in May 2027.

2. Upcoming FY27 Guide Risks being a Lose-Lose Situation. We see risk at Intuit's upcoming F4Q results and the subsequent guide for FY27 revenue. If management guides TurboTax in-line / above consensus' 6% YoY estimate, we fear

Morgan Stanley Downgrades Intuit (INTU) to Equalweight

Tue, 21 Jul 2026 02:35:37 -0400

Morgan Stanley analyst Adam Wood downgraded Intuit (NASDAQ: INTU) from Overweight to Equalweight with a price target of $335.00 (from $580.00).

The analyst comments: “Downgrade to Equal-weight on 3 Key Points:

Intuit (INTU) PT Lowered to $427 at Susquehanna

Mon, 20 Jul 2026 07:12:14 -0400

Susquehanna analyst James Friendman lowered the price target on Intuit (NASDAQ: INTU) to $427.00 (from $550.00) while maintaining a Positive rating.

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Insulet Corporation (NASDAQ: PODD); Intuit Inc. (INTU); and Power Solutions International, Inc. (NASDAQ: PSIX): Graba

Thu, 16 Jul 2026 08:13:13 -0400

PHILADELPHIA, July 16, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Insulet Corporation (NASDAQ: PODD); Intuit Inc. (INTU); and Power Solutions International, Inc. (NASDAQ: PSIX): Graba

Thu, 16 Jul 2026 08:13:13 -0400

PHILADELPHIA, July 16, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Insulet Corporation (NASDAQ: PODD); Intuit Inc. (INTU); and Power Solutions International, Inc. (NASDAQ: PSIX): Graba

Thu, 16 Jul 2026 08:13:13 -0400

PHILADELPHIA, July 16, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Insulet Corporation (NASDAQ: PODD); Intuit Inc. (INTU); and Power Solutions International, Inc. (NASDAQ: PSIX): Graba

Thu, 16 Jul 2026 08:13:13 -0400

PHILADELPHIA, July 16, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Insulet Corporation (NASDAQ: PODD); Intuit Inc. (INTU); and Power Solutions International, Inc. (NASDAQ: PSIX): Graba

Thu, 16 Jul 2026 08:13:13 -0400

PHILADELPHIA, July 16, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Insulet Corporation (NASDAQ: PODD); Intuit Inc. (INTU); and Power Solutions International, Inc. (NASDAQ: PSIX): Graba

Thu, 16 Jul 2026 08:13:13 -0400

PHILADELPHIA, July 16, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Insulet Corporation (NASDAQ: PODD); Intuit Inc. (INTU); and Power Solutions International, Inc. (NASDAQ: PSIX): Graba

Thu, 16 Jul 2026 08:13:13 -0400

PHILADELPHIA, July 16, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Insulet Corporation (NASDAQ: PODD); Intuit Inc. (INTU); and Power Solutions International, Inc. (NASDAQ: PSIX): Graba

Thu, 16 Jul 2026 08:13:13 -0400

PHILADELPHIA, July 16, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Insulet Corporation (NASDAQ: PODD); Intuit Inc. (INTU); and Power Solutions International, Inc. (NASDAQ: PSIX): Graba

Thu, 16 Jul 2026 08:13:13 -0400

PHILADELPHIA, July 16, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Insulet Corporation (NASDAQ: PODD); Intuit Inc. (INTU); and Power Solutions International, Inc. (NASDAQ: PSIX): Graba

Thu, 16 Jul 2026 08:13:13 -0400

PHILADELPHIA, July 16, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Insulet Corporation (NASDAQ: PODD); Intuit Inc. (INTU); and Power Solutions International, Inc. (NASDAQ: PSIX): Graba

Thu, 16 Jul 2026 08:13:13 -0400

PHILADELPHIA, July 16, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Insulet Corporation (NASDAQ: PODD); Intuit Inc. (INTU); and Power Solutions International, Inc. (NASDAQ: PSIX): Graba

Thu, 16 Jul 2026 08:13:13 -0400

PHILADELPHIA, July 16, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Insulet Corporation (NASDAQ: PODD); Intuit Inc. (INTU); and Power Solutions International, Inc. (NASDAQ: PSIX): Graba

Thu, 16 Jul 2026 08:13:13 -0400

PHILADELPHIA, July 16, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Insulet Corporation (NASDAQ: PODD); Intuit Inc. (INTU); and Power Solutions International, Inc. (NASDAQ: PSIX): Graba

Thu, 16 Jul 2026 08:13:13 -0400

PHILADELPHIA, July 16, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Insulet Corporation (NASDAQ: PODD); Intuit Inc. (INTU); and Power Solutions International, Inc. (NASDAQ: PSIX): Graba

Thu, 16 Jul 2026 08:13:13 -0400

PHILADELPHIA, July 16, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Insulet Corporation (NASDAQ: PODD); Intuit Inc. (INTU); and Power Solutions International, Inc. (NASDAQ: PSIX): Graba

Thu, 16 Jul 2026 08:13:13 -0400

PHILADELPHIA, July 16, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,